| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C0020969> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C0022688> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C0026473> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C0036859> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C0079189> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C0282554> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C0521117> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C1136181> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C1752856> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34209845_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Coccia_Eliana_Marina> <https://research.tib.eu/covid-19/entity/Etna_Marilena_Paola> <https://research.tib.eu/covid-19/entity/Ricci_Daniela> <https://research.tib.eu/covid-19/entity/Rizzo_Fabiana> <https://research.tib.eu/covid-19/entity/Sandini_Silvia> <https://research.tib.eu/covid-19/entity/Severa_Martina>
?:doi	701710.3390/ijms22137017
?:doi	<https://research.tib.eu/covid-19/entity/701710.3390/ijms22137017>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	International journal of molecular sciences
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34209845>
?:pmid	<https://research.tib.eu/covid-19/entity/34209845>
?:pmid	34209845
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.26
?:rankingScore_hIndex	95
?:title	Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34209845>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34209845>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all